Private Trust Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.29M | Sell |
4,573
-280
| -6% | -$134K | 0.18% | 115 |
|
|
2026
Q1 | $2.39M | Buy |
4,853
+75
| +2% | +$40.7K | 0.21% | 102 |
|
|
2025
Q4 | $2.77M | Buy |
4,778
+30
| +0.6% | +$17K | 0.24% | 82 |
|
|
2025
Q3 | $2.3M | Sell |
4,748
-146
| -3% | -$68K | 0.2% | 106 |
|
|
2025
Q2 | $1.98M | Buy |
4,894
+11
| +0.2% | +$4.6K | 0.19% | 115 |
|
|
2025
Q1 | $2.43M | Buy |
4,883
+324
| +7% | +$175K | 0.25% | 84 |
|
|
2024
Q4 | $2.37M | Sell |
4,559
-179
| -4% | -$98.4K | 0.24% | 86 |
|
|
2024
Q3 | $2.93M | Sell |
4,738
-560
| -11% | -$331K | 0.3% | 63 |
|
|
2024
Q2 | $2.93M | Sell |
5,298
-59
| -1% | -$33.8K | 0.32% | 60 |
|
|
2024
Q1 | $3.11M | Buy |
5,357
+570
| +12% | +$320K | 0.34% | 56 |
|
|
2023
Q4 | $2.54M | Sell |
4,787
-336
| -7% | -$163K | 0.3% | 66 |
|
|
2023
Q3 | $2.59M | Sell |
5,123
-1,472
| -22% | -$784K | 0.34% | 60 |
|
|
2023
Q2 | $3.44M | Buy |
6,595
+47
| +0.7% | +$25.4K | 0.43% | 40 |
|
|
2023
Q1 | $3.77M | Buy |
6,548
+1,626
| +33% | +$916K | 0.51% | 33 |
|
|
2022
Q4 | $2.71M | Sell |
4,922
-445
| -8% | -$236K | 0.4% | 51 |
|
|
2022
Q3 | $2.72M | Sell |
5,367
-209
| -4% | -$117K | 0.44% | 43 |
|
|
2022
Q2 | $3.03M | Sell |
5,576
-282
| -5% | -$155K | 0.47% | 36 |
|
|
2022
Q1 | $3.46M | Sell |
5,858
-9
| -0.2% | -$5.17K | 0.54% | 47 |
|
|
2021
Q4 | $3.92M | Sell |
5,867
-1,183
| -17% | -$739K | 0.54% | 43 |
|
|
2021
Q3 | $4.03M | Sell |
7,050
-303
| -4% | -$166K | 0.59% | 37 |
|
|
2021
Q2 | $3.71M | Sell |
7,353
-21
| -0.3% | -$9.91K | 0.56% | 40 |
|
|
2021
Q1 | $3.37M | Sell |
7,374
-265
| -3% | -$126K | 0.55% | 43 |
|
|
2020
Q4 | $3.56M | Buy |
7,639
+129
| +2% | +$60.5K | 0.6% | 40 |
|
|
2020
Q3 | $3.31M | Buy |
7,510
+171
| +2% | +$70.6K | 0.64% | 38 |
|
|
2020
Q2 | $2.69M | Sell |
7,339
-866
| -11% | -$290K | 0.56% | 44 |
|
|
2020
Q1 | $2.33M | Buy |
8,205
+3,553
| +76% | +$1.12M | 0.6% | 44 |
|
|
2019
Q4 | $1.51M | Buy |
4,652
+1,098
| +31% | +$333K | 0.28% | 95 |
|
|
2019
Q3 | $1.03M | Buy |
3,554
+281
| +9% | +$80.5K | 0.2% | 125 |
|
|
2019
Q2 | $961K | Buy |
3,273
+1,310
| +67% | +$361K | 0.19% | 130 |
|
|
2019
Q1 | $537K | Buy |
1,963
+233
| +13% | +$58K | 0.11% | 220 |
|
|
2018
Q4 | $387K | Buy |
1,730
+127
| +8% | +$29.8K | 0.09% | 243 |
|
|
2018
Q3 | $391K | Buy |
1,603
+36
| +2% | +$8.28K | 0.08% | 270 |
|
|
2018
Q2 | $324K | Sell |
1,567
-16
| -1% | -$3.4K | 0.07% | 284 |
|
|
2018
Q1 | $326K | Sell |
1,583
-62
| -4% | -$13K | 0.07% | 289 |
|
|
2017
Q4 | $312K | Buy |
1,645
+21
| +1% | +$4.02K | 0.07% | 289 |
|
|
2017
Q3 | $307K | Sell |
1,624
-19
| -1% | -$3.44K | 0.07% | 297 |
|
|
2017
Q2 | $286K | Buy |
1,643
+163
| +11% | +$27.4K | 0.06% | 305 |
|
|
2017
Q1 | $227K | Sell |
1,480
-3,918
| -73% | -$599K | 0.05% | 326 |
|
|
2016
Q4 | $761K | Sell |
5,398
-1,051
| -16% | -$155K | 0.18% | 135 |
|
|
2016
Q3 | $1.02M | Sell |
6,449
-390
| -6% | -$60.1K | 0.25% | 103 |
|
|
2016
Q2 | $1.01M | Buy |
6,839
+480
| +8% | +$70.8K | 0.26% | 100 |
|
|
2016
Q1 | $899K | Buy |
6,359
+3,800
| +148% | +$509K | 0.24% | 107 |
|
|
2015
Q4 | $362K | Sell |
2,559
-132
| -5% | -$17.6K | 0.1% | 218 |
|
|
2015
Q3 | $328K | Buy |
2,691
+419
| +18% | +$54.6K | 0.1% | 226 |
|
|
2015
Q2 | $293K | Buy |
2,272
+130
| +6% | +$16.9K | 0.08% | 251 |
|
|
2015
Q1 | $287K | Sell |
2,142
-13
| -0.6% | -$1.68K | 0.08% | 250 |
|
|
2014
Q4 | $269K | Buy |
2,155
+857
| +66% | +$104K | 0.09% | 241 |
|
|
2014
Q3 | $158K | Sell |
1,298
-112
| -8% | -$13.6K | 0.05% | 311 |
|
|
2014
Q2 | $166K | Buy |
1,410
+74
| +6% | +$8.71K | 0.05% | 313 |
|
|
2014
Q1 | $161K | Sell |
1,336
-82
| -6% | -$9.75K | 0.06% | 283 |
|
|
2013
Q4 | $158K | Sell |
1,418
-27
| -2% | -$2.69K | 0.06% | 248 |
|
|
2013
Q3 | $133K | Sell |
1,445
-22
| -1% | -$1.99K | 0.06% | 257 |
|
|
2013
Q2 | $124K | Buy |
+1,467
| New | +$122K | 0.06% | 255 |
|
Other funds holding TMO
Private Trust Company's TMO Position: Q2 2026 in Review
Private Trust Company reduced its Thermo Fisher Scientific (TMO) stake by 5.8% in Q2 2026, selling an estimated $134K and leaving 4,573 shares worth $2.29M. The position accounts for 0.18% of the portfolio, ranked #115.
Private Trust Company first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.03M in Q3 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Private Trust Company held 4,573 shares of Thermo Fisher Scientific worth $2.29M as of Q2 2026.
- Private Trust Company sold 280 Thermo Fisher Scientific shares in Q2 2026, an estimated $134K.
- Thermo Fisher Scientific made up 0.18% of Private Trust Company's portfolio in Q2 2026, its #115 holding.
- Private Trust Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Private Trust Company's Thermo Fisher Scientific position peaked at $4.03M in Q3 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.